New Business of Biosimilars

home page

Thank you to all who attended the 2009 Business of Biosimilars Event. The lively debate and discussion left speakers and attendees alike eager to find out what the future holds for the US biosmilars marketplace. If you were not able to join us, you can download the brochure or access the agenda-at-a-glance. Opt in today for updates on the 2010 conference!

Testimonials from the 2009 event!

  • “I think the conference was an excellent, balanced overview of the key issues with thoughtful and knowledgeable speakers and participants.  This is certainly going to grow in interest as a relevant issue in the health care area as we move toward Congressional passage of a biosimilar pathway.”
    -Henry G. Grabowski, PhD, Professor of Economics & Director of the Program in Pharmaceuticals & Health Economics, Duke University
  • “This was a great conference.  The speakers were outstanding.  I appreciate all the work you and your staff did to get all these great industry experts there and willing to speak.”
    -Jim Verzuh, Director of Marketing, BioScience Laboratories, Inc.

Future of BioPharma Blog

About the Business of Biosimilars Event

For over 10 years, IIR’s Generic Drug Summit has addressed the regulatory and legal issues impacting the generic drug industry. In 2009, we’ve expanded the event to deliver brand and generic companies innovative tools to compete in the business of biosimilars and biogenerics. The event is well positioned to become the leading business meeting for executives looking to profit in the emerging market of biosimilars and biogenerics.


Members Login
Co-Located With:
Drug Delivery